empty

ABPI

7 results found for: ABPI

Drug companies ‘in constant emergency’ due to Brexit uncertainty

A representative for UK drug manufacturers has told MPs that Brexit negotiators must reach a deal to prevent supply chain chaos. 

ABPI consults on major overhaul of Code of Practice

The proposals for the Code would result in the most significant structural change in nearly 30 years.

Torbett to take over as ABPI chief exec

Dr Richard Torbett takes over as ABPI chief exec in Jnuary 2020.

UK leads Europe in early clinical research, but faces challenges …

The UK leads on early stage clinical trials but falls behind Germany and the US when it comes to later-stage research.

Parallel trade ban on 30 drugs to stop Brexit profiteering

The Times says ministers will ban the export of up to 30 drugs to prevent wholesaler profiteering in the run-up to no-deal Brexit.

NAO: Still significant gaps in no-deal medicines planning

There still significant gaps in the government’s efforts to safeguard medicines supply after a no-deal Brexit.

New report highlights imbalance in dermatology services

More than three million hours were spent on skin conditions in primary care in 2016 at a cost tothe NHS of £723 million each year, according to a new report4 from the ABPI produced in collaboration with an independent Dermatology Expert Working Group (EWG).



This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Independent Pharmacist's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.